Glenn Gossage

Array ( [id] => 4663195 [patent_doc_number] => 20080254102 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2008-10-16 [patent_title] => 'Orally administered agent and an orally administered agent/supporting substrate complex' [patent_app_type] => utility [patent_app_number] => 10/690811 [patent_app_country] => US [patent_app_date] => 2003-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11090 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0254/20080254102.pdf [firstpage_image] =>[orig_patent_app_number] => 10690811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663195 [patent_doc_number] => 20080254102 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2008-10-16 [patent_title] => 'Orally administered agent and an orally administered agent/supporting substrate complex' [patent_app_type] => utility [patent_app_number] => 10/690811 [patent_app_country] => US [patent_app_date] => 2003-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11090 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0254/20080254102.pdf [firstpage_image] =>[orig_patent_app_number] => 10690811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7159415 [patent_doc_number] => 20050084455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Inhalable biodegradable microparticles for target-specific drug delivery in tuberculosis and a process thereof' [patent_app_type] => utility [patent_app_number] => 10/685567 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4130 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084455.pdf [firstpage_image] =>[orig_patent_app_number] => 10685567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4450894 [patent_doc_number] => 07964217 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor' [patent_app_type] => utility [patent_app_number] => 10/684893 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7134 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964217.pdf [firstpage_image] =>[orig_patent_app_number] => 10684893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169841 [patent_doc_number] => 20040077708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Stablized pharmaceutical composition comprising an amorphous active substance' [patent_app_type] => new [patent_app_number] => 10/683683 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3339 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077708.pdf [firstpage_image] =>[orig_patent_app_number] => 10683683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467154 [patent_doc_number] => 20040198813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Novel microemulsion and micelle systems for solubilizing drugs' [patent_app_type] => new [patent_app_number] => 10/679581 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6536 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198813.pdf [firstpage_image] =>[orig_patent_app_number] => 10679581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387218 [patent_doc_number] => 20040082663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Imidazoline receptor binding compounds' [patent_app_type] => new [patent_app_number] => 10/663879 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7120 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082663.pdf [firstpage_image] =>[orig_patent_app_number] => 10663879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432814 [patent_doc_number] => 20040209852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Formulations and methods for treating rhinosinusitis' [patent_app_type] => new [patent_app_number] => 10/657550 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10499 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209852.pdf [firstpage_image] =>[orig_patent_app_number] => 10657550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11389652 [patent_doc_number] => 09550888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-24 [patent_title] => 'Low viscosity filler composition of boron nitride particles of spherical geometry and process' [patent_app_type] => utility [patent_app_number] => 10/652283 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3568 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10652283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872780 [patent_doc_number] => 20060165620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Coloured gloss pigments having at least one coating of siox, with x=0.03 to 0.95 for use in cosmetic and personal care formulations' [patent_app_type] => utility [patent_app_number] => 10/524457 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16912 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165620.pdf [firstpage_image] =>[orig_patent_app_number] => 10524457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7390232 [patent_doc_number] => 20040037866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Composition and method for the treatment and prevention of adhesions' [patent_app_type] => new [patent_app_number] => 10/643664 [patent_app_country] => US [patent_app_date] => 2003-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6995 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20040037866.pdf [firstpage_image] =>[orig_patent_app_number] => 10643664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281344 [patent_doc_number] => 20040063721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Agonism of the 5HT2A receptor for treatment of thermoregulatory dysfunction' [patent_app_type] => new [patent_app_number] => 10/641226 [patent_app_country] => US [patent_app_date] => 2003-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5758 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063721.pdf [firstpage_image] =>[orig_patent_app_number] => 10641226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7312171 [patent_doc_number] => 20040033261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Gellan gum tablet film coating' [patent_app_type] => new [patent_app_number] => 10/637546 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13551 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033261.pdf [firstpage_image] =>[orig_patent_app_number] => 10637546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089804 [patent_doc_number] => 20050009917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Antipruritic agent' [patent_app_type] => utility [patent_app_number] => 10/493693 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6593 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009917.pdf [firstpage_image] =>[orig_patent_app_number] => 10493693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034301 [patent_doc_number] => 20050032811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Methods for administering aripiprazole' [patent_app_type] => utility [patent_app_number] => 10/635221 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2404 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032811.pdf [firstpage_image] =>[orig_patent_app_number] => 10635221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8351652 [patent_doc_number] => 08246980 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Transdermal delivery system' [patent_app_type] => utility [patent_app_number] => 10/627990 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6151 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10627990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5112566 [patent_doc_number] => 20070196481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Sustained-release tablet composition' [patent_app_type] => utility [patent_app_number] => 10/626379 [patent_app_country] => US [patent_app_date] => 2003-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11132 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196481.pdf [firstpage_image] =>[orig_patent_app_number] => 10626379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7446024 [patent_doc_number] => 20040067213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Cosmetic and/or pharmaceutical agents' [patent_app_type] => new [patent_app_number] => 10/466618 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4399 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067213.pdf [firstpage_image] =>[orig_patent_app_number] => 10466618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10095783 [patent_doc_number] => 09132078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Dual phase cosmetic composition' [patent_app_type] => utility [patent_app_number] => 10/618803 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2092 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10618803 [rel_patent_id] =>[rel_patent_doc_number] =>)